Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anatara Lifesciences.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Hearts are pumping as Anteris shares debut on the Nasdaq
Health & Biotech
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
News
Market Highlights: US GDP boosts market confidence, and 5 ASX small caps to watch today
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: AVITA flies as high as 24pc after providing a big, bullish guidance
News
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Benchmark ends an ordinary Monday on a low, despite Dacian’s big gold delivery
Health & Biotech
ASX Health Stocks: Anatara moves rapidly to Stage 2 in Phase 1/2 bowel syndrome trial
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
Health & Biotech
ASX Health Stocks: Memphasys says Felix can separate sperm better than current techniques
News
Market Highlights: Binance’s CZ sued by SEC, as market awaits RBA decision at 2.30pm
Health & Biotech
ASX Health Stocks: Volpara jumps 10pc as US FDA makes new ruling on ‘dense breasts’ language
News
LAST ORDERS: Today’s semi-serious look at some very serious ASX stuff
Health & Biotech
ASX Health Stocks: Althea to start selling medicinal cannabis in Ireland
Health & Biotech
